Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cardiol Therapeutics Inc

1.46
+0.02001.39%
Post-market: 1.44-0.0200-1.37%19:10 EDT
Volume:177.05K
Turnover:258.09K
Market Cap:120.67M
PE:-4.42
High:1.50
Open:1.42
Low:1.38
Close:1.44
Loading ...

Cardiol Therapeutics initiated with a Buy at H.C. Wainwright

TIPRANKS
·
02 Jun

Cardiol Therapeutics Inc expected to post a loss of 13 cents a share - Earnings Preview

Reuters
·
10 May

Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors

Newsfile
·
29 Apr

Cardiol Therapeutics Inc expected to post a loss of 13 cents a share - Earnings Preview

Reuters
·
19 Apr

Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis

Newsfile
·
16 Apr

Cardiol Therapeutics Inc expected to post a loss of 13 cents a share - Earnings Preview

Reuters
·
09 Apr

Cardiol Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
02 Apr

We're Keeping An Eye On Cardiol Therapeutics' (TSE:CRDL) Cash Burn Rate

Simply Wall St.
·
02 Apr

Cardiol Therapeutics Announces Year-End 2024 Update on Operations

Newsfile
·
01 Apr

Cardiol Therapeutics Inc expected to post a loss of 12 cents a share - Earnings Preview

Reuters
·
29 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
27 Mar

Cardiol Therapeutics to Present at TD Cowen 45th Annual Health Care Conference

Newsfile
·
03 Mar

Cardiol Therapeutics Announces Publication of Research in the Journal of the American College of Cardiology: Basic to Translational Science That Supports Development of Its Proprietary Subcutaneous Drug Candidate, CRD-38, for the Treatment of Heart Failure

Newsfile
·
20 Feb

Zacks Industry Outlook Highlights Corcept, Amneal, Dyne, Nektar and Cardiol

Zacks
·
03 Feb

5 Small Drug Stocks to Add to Your Kitty in the Trump 2.0 Era

Zacks
·
31 Jan